Show simple item record

dc.contributor.authorNewton, G
dc.contributor.authorWynne, G
dc.contributor.authorKeily, J
dc.contributor.authorSmyth, D
dc.contributor.authorCrew, A
dc.coverage.spatialInternational
dc.date.accessioned2020-08-19T10:04:58Z
dc.date.issued2005-09-27
dc.identifierhttps://worldwide.espacenet.com/
dc.identifierUS75234204A
dc.identifierUS6949563 (and associated family)
dc.identifier.citation2005
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3988
dc.description.abstractCompounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein R1 is R2 is and R3 is C 0-4 alkyl, are useful in the treatment of cancer.
dc.languageeng
dc.language.isoeng
dc.subjectKinase
dc.subjectc-Kit
dc.subjectKDR
dc.title(2-carboxamido)(3-amino)thiophene compounds
dc.typePatent
rioxxterms.licenseref.startdate2005-09-27
rioxxterms.typeOther
pubs.filed-date2004-01-06
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 3
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 3
pubs.patent-statusGranted in multiple territories
pubs.embargo.termsNot known
icr.researchteamMedicinal Chemistry 3en_US
dc.contributor.icrauthorNewton, Gary


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record